RESEARCHER PROFILE
Dr Rikki Jones (Filmed July 2024)
Senior Lecturer in Nursing
University of New England,
New South Wales, Australia
Dr Rikki Jones completed her Bachelor of Nursing degree at the University of New England (UNE) in 2000 and a Ph.D in Nursing at UNE in 2021. She has over 17 years of clinical nursing experience in emergency nursing, community health, rural and remote nursing, and theatre nursing. Since undertaking her role at UNE in 2017, Dr Jones has gained extensive experience in curriculum development/design, unit coordination, and is passionate quality meaningful research and student support.
At UNE, Dr Jones has been actively involved in and undertaking leadership roles in research, teaching and student support. Dr Jones is the HDR (higher degree research) coordinator for the School of Health (SOH), and the Chair of Research Committee SOH. Recently she has been awarded an MRFF (Medical Research Future Funds)- Early to Mid-Career Researcher Initiative 2023 for her research focusing on regional, rural and remote first responders’ mental health.
Dr Jones has been awarded to date a total of over AUD$430,000 in research funding. She is currently leading four large national research teams focusing on rural health and sustainable rural health workforce (include mental health of first responders, sexual violence in rural Australia, virtual simulated nursing placements, and nursing students experience with online learning, connection and transitioning to practice).
-
Targeting chemotherapy resistance in ovarian cancer patients
Dr Alex Cole, from the Centenary Institute’s Centre for Biomedical AI, is now leading the research focused on developing a new treatment to counteract a protein called follistatin (FST), known for making ovarian cancer cells resistant to chemotherapy.
By employing cutting-edge molecular biology and directed evolution techniques, the project aims to create nanobodies—small, precise molecules—that can block FST. If successful, these nanobodies could enhance the effectiveness of chemotherapy and improve ovarian cancer treatment rates.
-
Infections and other lung diseases using models of human lung tissue grown from stem cells
Dr Rhiannon Werder is a Team Leader at Murdoch Children’s Research Institute leading a multidisciplinary team, combining expertise in stem cell biology and immunology, to develop new therapies for lung diseases. Her research centres around induced pluripotent stem cells to investigate respiratory diseases, spanning acute respiratory infections to chronic lung diseases. Using stem cells, Dr Werder’s team creates models of human lung tissue. With these models, Dr Werder is investigating how human-specific pathogens infect different regions of the lung, the ensuing immune responses, and how the lung repairs itself after infections, especially in people with preexisting lung diseases.
-
Podiatric Research In Children, the workforce and the LGBTQIA+ community
Professor Williams holds the role of Deputy Head of School, School of Primary and Allied Health Care, and course coordinator of the Doctor of Podiatric Medicine degree. She is a podiatrist, and has held professional roles in community health, acute and subacute services in child health care teams, research leadership and professional governance.
